OBJECTIVE: To examine the relationship between markers of vascular dysfunction and neurodevelopmental status in pediatric HIV disease. DESIGN: A cross-sectional design within a prospective, 15-site cohort study conducted in the United States. METHODS: Nine vascular biomarkers were examined in 89 HIV-infected children: soluble P-selectin/sCD62P, fibrinogen, adiponectin, monocyte chemoattractant protein-1/CCL-2, interleukin-6, C-reactive protein, soluble vascular cell adhesion molecule-1/sCD106, sE-selectin/sCD62E, and soluble intercellular adhesion molecule-1/sCD54. The Wechsler Intelligence Scale for Children-Fourth edition (WISC-IV) was administered yielding indices for verbal comprehension, perceptual reasoning, working memory and processing speed, and overall composite Full-Scale IQ score. Linear regression models were used to evaluate neurodevelopmental status (measured by WISC-IV scores) as a function of each biomarker while adjusting for demographics, disease severity, and receipt of HAART. Biomarker levels were evaluated in quartiles to evaluate trends in WISC-IV responses. RESULTS: Among the 89 HIV-infected children (median age = 12 years), 56% were girls, 71% black, 16% Hispanic, and 43% had yearly household income below US $20,000. Log (soluble P-selectin) was significantly correlated with all WISC-IV scores; adjusted slopes showed 6-11-point average decrease in scores for each one log unit increase in soluble P-selectin. Final linear regression models for log (fibrinogen) adjusted for sociodemographic and disease characteristics also indicated a negative correlation with all WISC-IV scores (13-30-point decrease for each one log unit increase in fibrinogen); these decreases were significant in the verbal comprehension, perceptual reasoning, and Full-Scale IQ scores. CONCLUSION: Proinflammatory microvascular and immunologic mechanisms may be involved in neurodevelopmental impairment in children with perinatally acquired HIV disease.
OBJECTIVE: To examine the relationship between markers of vascular dysfunction and neurodevelopmental status in pediatric HIV disease. DESIGN: A cross-sectional design within a prospective, 15-site cohort study conducted in the United States. METHODS: Nine vascular biomarkers were examined in 89 HIV-infectedchildren: soluble P-selectin/sCD62P, fibrinogen, adiponectin, monocyte chemoattractant protein-1/CCL-2, interleukin-6, C-reactive protein, soluble vascular cell adhesion molecule-1/sCD106, sE-selectin/sCD62E, and soluble intercellular adhesion molecule-1/sCD54. The Wechsler Intelligence Scale for Children-Fourth edition (WISC-IV) was administered yielding indices for verbal comprehension, perceptual reasoning, working memory and processing speed, and overall composite Full-Scale IQ score. Linear regression models were used to evaluate neurodevelopmental status (measured by WISC-IV scores) as a function of each biomarker while adjusting for demographics, disease severity, and receipt of HAART. Biomarker levels were evaluated in quartiles to evaluate trends in WISC-IV responses. RESULTS: Among the 89 HIV-infectedchildren (median age = 12 years), 56% were girls, 71% black, 16% Hispanic, and 43% had yearly household income below US $20,000. Log (soluble P-selectin) was significantly correlated with all WISC-IV scores; adjusted slopes showed 6-11-point average decrease in scores for each one log unit increase in soluble P-selectin. Final linear regression models for log (fibrinogen) adjusted for sociodemographic and disease characteristics also indicated a negative correlation with all WISC-IV scores (13-30-point decrease for each one log unit increase in fibrinogen); these decreases were significant in the verbal comprehension, perceptual reasoning, and Full-Scale IQ scores. CONCLUSION: Proinflammatory microvascular and immunologic mechanisms may be involved in neurodevelopmental impairment in children with perinatally acquired HIV disease.
Authors: M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn Journal: Diabetologia Date: 2003-04-10 Impact factor: 10.122
Authors: N Ouchi; S Kihara; Y Arita; Y Okamoto; K Maeda; H Kuriyama; K Hotta; M Nishida; M Takahashi; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa Journal: Circulation Date: 2000-09-12 Impact factor: 29.690
Authors: Enrique Gonzalez; Brad H Rovin; Luisa Sen; Glen Cooke; Rahul Dhanda; Srinivas Mummidi; Hemant Kulkarni; Michael J Bamshad; Vanessa Telles; Stephanie A Anderson; Elizabeth A Walter; Kevin T Stephan; Michael Deucher; Andrea Mangano; Rosa Bologna; Seema S Ahuja; Matthew J Dolan; Sunil K Ahuja Journal: Proc Natl Acad Sci U S A Date: 2002-10-08 Impact factor: 11.205
Authors: C Weber; K U Belge; P von Hundelshausen; G Draude; B Steppich; M Mack; M Frankenberger; K S Weber; H W Ziegler-Heitbrock Journal: J Leukoc Biol Date: 2000-05 Impact factor: 4.962
Authors: T Fischer-Smith; S Croul; A E Sverstiuk; C Capini; D L'Heureux; E G Régulier; M W Richardson; S Amini; S Morgello; K Khalili; J Rappaport Journal: J Neurovirol Date: 2001-12 Impact factor: 2.643
Authors: Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke Journal: ACS Chem Neurosci Date: 2015-06-19 Impact factor: 4.418
Authors: Cynthia Fair; Lori Wiener; Sima Zadeh; Jamie Albright; Claude Ann Mellins; Michael Mancilla; Vicki Tepper; Connie Trexler; Julia Purdy; Janet Osherow; Susan Lovelace; Suad Kapetanovic Journal: Matern Child Health J Date: 2013-07
Authors: Suad Kapetanovic; Ryan E Wiegand; Ken Dominguez; Dean Blumberg; Beverly Bohannon; John Wheeling; Richard Rutstein Journal: AIDS Patient Care STDS Date: 2011-07-11 Impact factor: 5.078
Authors: Sharon L Nichols; Miriam C Chernoff; Kathleen Malee; Patricia A Sirois; Paige L Williams; Veronica Figueroa; Steven P Woods Journal: Pediatr Infect Dis J Date: 2016-06 Impact factor: 2.129
Authors: Allison Ross Eckard; Julia C Rosebush; Mary Ann O'Riordan; Chanda C Graves; Ashley Alexander; Anita K Grover; S Thera Lee; Jakob G Habib; Joshua H Ruff; Ann Chahroudi; Grace A McComsey Journal: Antivir Ther Date: 2017
Authors: Thomas R Ziegler; Suzanne E Judd; Joshua H Ruff; Grace A McComsey; Allison Ross Eckard Journal: AIDS Res Hum Retroviruses Date: 2017-02-27 Impact factor: 2.205